tradingkey.logo

Clearpoint Neuro Inc

CLPT
13.460USD
+0.890+7.08%
종가 02/06, 16:00ET시세는 15분 지연됩니다
382.64M시가총액
손실P/E TTM

Clearpoint Neuro Inc

13.460
+0.890+7.08%

자세한 내용은 Clearpoint Neuro Inc 회사

ClearPoint Neuro, Inc. is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The Company is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. The Company also provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide.

Clearpoint Neuro Inc 정보

종목 코드 CLPT
회사 이름Clearpoint Neuro Inc
상장일Jul 03, 2019
CEOBurnett (Joseph Michael)
직원 수115
유형Ordinary Share
회계 연도 종료Jul 03
주소120 S. Sierra Avenue
도시SOLANA BEACH
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호92075
전화19499006833
웹사이트https://www.clearpointneuro.com/
종목 코드 CLPT
상장일Jul 03, 2019
CEOBurnett (Joseph Michael)

Clearpoint Neuro Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
276.33K
--
Mr. Timothy T. Richards
Mr. Timothy T. Richards
Independent Director
Independent Director
79.75K
+884.00%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Independent Director
50.52K
+21093.00%
Mr. Mazin Sabra
Mr. Mazin Sabra
Chief Operating Officer
Chief Operating Officer
44.47K
+386.00%
Ms. Lynnette C. Fallon
Ms. Lynnette C. Fallon
Independent Director
Independent Director
40.90K
-10200.00%
Mr. Pascal E.R. Girin
Mr. Pascal E.R. Girin
Independent Director
Independent Director
--
--
Mr. R. John Fletcher
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. B. Kristine (Kris) Johnson
Ms. B. Kristine (Kris) Johnson
Independent Director
Independent Director
--
--
Mr. Danilo D' Alessandro
Mr. Danilo D' Alessandro
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Linda M. Liau
Dr. Linda M. Liau
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
276.33K
--
Mr. Timothy T. Richards
Mr. Timothy T. Richards
Independent Director
Independent Director
79.75K
+884.00%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Independent Director
50.52K
+21093.00%
Mr. Mazin Sabra
Mr. Mazin Sabra
Chief Operating Officer
Chief Operating Officer
44.47K
+386.00%
Ms. Lynnette C. Fallon
Ms. Lynnette C. Fallon
Independent Director
Independent Director
40.90K
-10200.00%
Mr. Pascal E.R. Girin
Mr. Pascal E.R. Girin
Independent Director
Independent Director
--
--

수익 분석

통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Products: Functional neurosurgery
3.42M
38.62%
Services: Biologics and drug delivery
3.11M
35.10%
Products: Biologics and drug delivery
1.29M
14.58%
Product Systems and software products
647.00K
7.30%
Services: Capital equipment and other
390.00K
4.40%
지역별USD
이름
수익
비율
United States
8.86M
100.00%
사업별
지역별
사업별USD
이름
수익
비율
Products: Functional neurosurgery
3.42M
38.62%
Services: Biologics and drug delivery
3.11M
35.10%
Products: Biologics and drug delivery
1.29M
14.58%
Product Systems and software products
647.00K
7.30%
Services: Capital equipment and other
390.00K
4.40%

주식 보유 통계

마지막 업데이트: Fri, Feb 6
마지막 업데이트: Fri, Feb 6
주주
주주 유형
주주
주주
비율
The Vanguard Group, Inc.
5.94%
BlackRock Institutional Trust Company, N.A.
5.47%
Bigger Capital Funds, LP
4.48%
PTC Therapeutics Inc
3.01%
Geode Capital Management, L.L.C.
2.21%
기타
78.90%
주주
주주
비율
The Vanguard Group, Inc.
5.94%
BlackRock Institutional Trust Company, N.A.
5.47%
Bigger Capital Funds, LP
4.48%
PTC Therapeutics Inc
3.01%
Geode Capital Management, L.L.C.
2.21%
기타
78.90%
주주 유형
주주
비율
Investment Advisor
21.26%
Investment Advisor/Hedge Fund
10.48%
Hedge Fund
8.69%
Individual Investor
4.99%
Corporation
3.01%
Research Firm
1.38%
Bank and Trust
0.10%
Pension Fund
0.03%
Insurance Company
0.03%
기타
50.03%

기관 주식 보유

마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
238
11.91M
42.82%
-795.00
2025Q3
241
11.91M
44.93%
+805.07K
2025Q2
228
11.11M
37.29%
+1.29M
2025Q1
216
9.82M
36.04%
-268.85K
2024Q4
204
9.20M
33.04%
+1.04M
2024Q3
190
8.15M
32.05%
-235.56K
2024Q2
185
8.39M
33.08%
-454.38K
2024Q1
183
8.85M
30.95%
+359.48K
2023Q4
183
7.82M
35.41%
+717.11K
2023Q3
184
7.11M
35.71%
+336.40K
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
The Vanguard Group, Inc.
1.50M
5.03%
+22.52K
+1.53%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
1.63M
5.47%
+127.17K
+8.48%
Sep 30, 2025
Bigger Capital Funds, LP
1.29M
4.34%
+126.00K
+10.80%
Sep 30, 2025
PTC Therapeutics Inc
894.58K
3.01%
--
--
Aug 23, 2024
Geode Capital Management, L.L.C.
656.40K
2.21%
+31.60K
+5.06%
Sep 30, 2025
State Street Investment Management (US)
482.65K
1.62%
+149.27K
+44.77%
Sep 30, 2025
Two Sigma Investments, LP
442.93K
1.49%
+421.00K
+1919.91%
Sep 30, 2025
Bigger (Michael)
378.69K
1.27%
--
--
Sep 30, 2025
UBS Financial Services, Inc.
360.70K
1.21%
+205.29K
+132.10%
Sep 30, 2025
District 2 Capital LP
307.75K
1.03%
-122.42K
-28.46%
Sep 30, 2025
더 보기

관련 ETF

마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
Invesco NASDAQ Future Gen 200 ETF
1.19%
iShares Neuroscience and Healthcare ETF
0.94%
iShares Micro-Cap ETF
0.12%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.09%
Vanguard US Momentum Factor ETF
0.06%
Motley Fool Next Index ETF
0.03%
Invesco Russell 2000 Dynamic Multifactor ETF
0.03%
iShares Russell 2000 Growth ETF
0.03%
iShares Russell 2000 ETF
0.02%
Proshares Ultra Russell 2000
0.02%
더 보기
Invesco NASDAQ Future Gen 200 ETF
비율1.19%
iShares Neuroscience and Healthcare ETF
비율0.94%
iShares Micro-Cap ETF
비율0.12%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
비율0.09%
Vanguard US Momentum Factor ETF
비율0.06%
Motley Fool Next Index ETF
비율0.03%
Invesco Russell 2000 Dynamic Multifactor ETF
비율0.03%
iShares Russell 2000 Growth ETF
비율0.03%
iShares Russell 2000 ETF
비율0.02%
Proshares Ultra Russell 2000
비율0.02%

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
KeyAI